{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:55:12Z","timestamp":1780340112950,"version":"3.54.1"},"reference-count":92,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives\/Methods: Atopic dermatitis (AD) impacts various aspects of patients\u2019 lives including personal life, psychological aspects\/disturbances (e.g., depression, anxiety, or even suicidal thoughts), school, and work-related activities, including career advancement. The aim of this narrative review is to present the latest information available on how to best approach AD patient management, as well as decisions regarding standard\/advanced systemic therapy, by gathering evidence from the relevant medical literature (PubMed and other prominent medical databases). Results: Thus, AD patient management and decisions regarding advanced\/systemic therapy are complex, requiring the consideration of multiple disease-related factors: age; disease severity; patient medical history and comorbidities; previous topical therapy use and any adverse reactions; treatment efficacy concerns; patient preferences, expectations and fears; pregnancy planning; ability and willingness to adhere to the treatment regimen; impact on related risks; and any associated psychological or psychiatric issues. Current guidelines and systematic reviews support the safety and efficacy of systemic therapy including conventional drugs (cyclosporine, methotrexate, and azathioprine), biologics (dupilumab and tralokinumab), and JAK inhibitors (baricitinib, upadacitinib, and abrocitinib) recommended for treating moderate and severe AD. Recently, additional biologics have been evaluated in clinical trials, including lebrikizumab, nemolizumab, eblasakimab, and OX40\/OX40L, among others. Conclusions: The most recently suggested approach to treating AD patients suggests focusing on therapy that targets and achieves minimal disease activity (MDA), where therapy decisions are informed by both the patient and the clinician. Available data also indicate the importance of a personalized, stepwise, and multidisciplinary approach. This type of approach promotes patient compliance, satisfaction with therapy, and increased engagement, which all lead to better patient outcomes.<\/jats:p>","DOI":"10.3390\/ph17111455","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T06:55:37Z","timestamp":1730357737000},"page":"1455","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Atopic Dermatitis-Related Problems in Daily Life, Goals of Therapy and Deciding Factors for Systemic Therapy: A Review"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7494-5742","authenticated-orcid":false,"given":"Liborija","family":"Lugovi\u0107-Mihi\u0107","sequence":"first","affiliation":[{"name":"Department of Dermatovenereology, University Hospital Center Sestre Milosrdnice, 10000 Zagreb, Croatia"},{"name":"School of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ema","family":"Barac","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, University Hospital Center Sestre Milosrdnice, 10000 Zagreb, Croatia"},{"name":"Family Physician Office, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Toma\u0161evi\u0107","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, University Hospital Center Sestre Milosrdnice, 10000 Zagreb, Croatia"},{"name":"School of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6759-8364","authenticated-orcid":false,"given":"Ena","family":"Para\u0107","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Immunology, Allergology, and Rheumatology, Department of Paediatrics, University Children\u2019s Hospital, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucija","family":"Zanze","sequence":"additional","affiliation":[{"name":"Family Physician Office, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ljevar","sequence":"additional","affiliation":[{"name":"Family Physician Office, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Dola\u010dki","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, University Hospital Center Sestre Milosrdnice, 10000 Zagreb, Croatia"},{"name":"School of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5379-9846","authenticated-orcid":false,"given":"Maja","family":"\u0160trajtenberger","sequence":"additional","affiliation":[{"name":"School of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia"},{"name":"Department of Pulmonology, Special Hospital for Pulmonary Diseases, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/DER.0000000000000907","article-title":"Meeting the needs of patients with atopic dermatitis: A multidisciplinary approach","volume":"33","author":"Russo","year":"2022","journal-title":"Dermatitis"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lugovi\u0107-Mihi\u0107, L., Me\u0161trovi\u0107-\u0160tefekov, J., Poto\u010dnjak, I., Cindri\u0107, T., Ili\u0107, I., Lovri\u0107, I., Skalicki, L., Be\u0161li\u0107, I., and Pondeljak, N. (2023). Atopic dermatitis: Disease features, therapeutic options, and a multidisciplinary approach. Life, 13.","DOI":"10.3390\/life13061419"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jval.2020.08.2025","article-title":"Prevalence and clinical profile of atopic dermatitis (AD) in England\u2014A population-based cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES)","volume":"23","author":"Ameen","year":"2020","journal-title":"Value Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/jdv.15919","article-title":"Characterizing treatment-related patient needs in atopic eczema: Insights for personalized goal-oriented care","volume":"34","author":"Augustin","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e13606","DOI":"10.1111\/dth.13606","article-title":"When life is itchy: What harms, helps, and heals from a patient\u2019s perspective? Differences and similarities in skin diseases","volume":"33","author":"Chee","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13555-020-00356-0","article-title":"Qualitative assessment of adult patients\u2019 perceptions of atopic dermatitis using natural language processing analysis in a cross-sectional study","volume":"10","author":"Falissard","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Xie, Q.W., Dai, X., Tang, X., Chan, C.H.Y., and Chan, C.L.W. (2019). Risk of mental disorders in children and adolescents with atopic dermatitis: A systematic review and meta-analysis. Front. Psychol., 10.","DOI":"10.3389\/fpsyg.2019.01773"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13052-020-0777-9","article-title":"Pruritus in pediatric patients with atopic dermatitis: A multidisciplinary approach-summary document of the Italian expert group","volume":"46","author":"Rotunno","year":"2020","journal-title":"Ital. J. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-021-00266-6","article-title":"Atopic dermatitis: An expanded therapeutic framework for a complex disease","volume":"21","author":"Bieber","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jaci.2007.11.004","article-title":"Is eczema really on the increase worldwide?","volume":"121","author":"Williams","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/jdv.15634","article-title":"Atopic eczema: Disease burden and individual suffering\u2014Results from a large EU study in adults","volume":"33","author":"Ring","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjd.19580","article-title":"The global burden of atopic dermatitis: Lessons from the Global Burden of Disease Study 1990\u20132017","volume":"184","author":"Laughter","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s13555-022-00819-6","article-title":"The burden of atopic dermatitis in adults and adolescents: A systematic review of the literature","volume":"12","author":"Fasseeh","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.2340\/00015555-3416","article-title":"Sleep disorders in patients with urticaria and atopic dermatitis: An underestimated burden","volume":"100","author":"Mann","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Pedersen, C.J., Uddin, M.J., Saha, S.K., and Darmstadt, G.L. (2021). Prevalence and psychosocial impact of atopic dermatitis in Bangladeshi children and families. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0249824"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ad.2019.03.018","article-title":"Psychosocial impact of atopic dermatitis in adults: A qualitative study","volume":"111","author":"Marron","year":"2020","journal-title":"Actas Dermosfiliogr."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Devleesschauwer, B., Maertens de Noordhout, C., Smit, G.S., Duchateau, L., Dorny, P., Stein, C., Van Oyen, H., and Speybroeck, N. (2014). Quantifying the burden of disease to support public health policy in Belgium: Opportunities and limitations. BMC Public Health, 14.","DOI":"10.1186\/1471-2458-14-1196"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"746","DOI":"10.5114\/ada.2020.95028","article-title":"Melatonin and sleep disorders in patients with severe atopic dermatitis","volume":"38","author":"Jaworek","year":"2021","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Be\u0161li\u0107, I., Lugovi\u0107-Mihi\u0107, L., Vrtari\u0107, A., Be\u0161li\u0107, A., \u0160krinjar, I., Han\u017eek, M., Crnkovi\u0107, D., and Artukovi\u0107, M. (2023). Melatonin in dermatologic allergic diseases and other skin conditions: Current trends and reports. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24044039"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/DER.0000000000000161","article-title":"Burden of sleep and fatigue in US adults with atopic dermatitis","volume":"27","author":"Yu","year":"2016","journal-title":"Dermatitis"},{"key":"ref_21","first-page":"297","article-title":"Psychological stress in patients with atopic dermatitis","volume":"26","author":"Kuna","year":"2018","journal-title":"Acta Dermatovenerol. Croat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2340\/00015555-2797","article-title":"Psychological health status and health-related quality of life in adults with atopic dermatitis: A national cross-sectional study in South Korea","volume":"98","author":"Lee","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/1346-8138.14947","article-title":"Health-care resource use and current treatment of adult atopic dermatitis patients in Japan: A retrospective claims database analysis","volume":"46","author":"Igarashi","year":"2019","journal-title":"J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jaad.2020.05.041","article-title":"Association of atopic dermatitis severity with cognitive function in adults","volume":"83","author":"Silverberg","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/1346-8138.14218","article-title":"The burden of atopic dermatitis among Japanese adults: An analysis of data from the 2013 National Health and Wellness Survey","volume":"45","author":"Arima","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaad.2019.03.037","article-title":"Disease burden in adults with atopic dermatitis: Analysis of survey data from France, Germany, Italy, Spain, and the United Kingdom","volume":"81","author":"Eckert","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","first-page":"9524","article-title":"The anxiety and depression disorder in adults with atopic dermatitis: Experience of a dermatology hospital","volume":"15","author":"Vinh","year":"2022","journal-title":"Dermatol. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kwon, J.A., Park, E.-C., Lee, M., Yoo, K.-B., and Park, S. (2013). Does stress increase the risk of atopic dermatitis in adolescents? Results of the Korean Youth Risk Behavior Web-Based Survey (KYRBWS-VI). PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067890"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2340\/00015555-1415","article-title":"Psychophysiological effects of stress management in patients with atopic dermatitis: A randomized controlled trial","volume":"93","author":"Schut","year":"2013","journal-title":"Acta Derm. Venereol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000525901","article-title":"The COVID-19 pandemic and recent earthquake in Zagreb together significantly increased the disease severity of patients with atopic dermatitis","volume":"239","author":"Bulat","year":"2023","journal-title":"Dermatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.14816\/sky.2015.26.1.111","article-title":"Factors affecting life satisfaction among adolescents with atopic dermatitis","volume":"26","author":"Choi","year":"2015","journal-title":"Stud. Korean Youth"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/jamadermatol.2018.4566","article-title":"Association between atopic dermatitis and suicidality: A systematic review and meta-analysis","volume":"155","author":"Sandhu","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.clinthera.2020.03.008","article-title":"Stress-induced interaction of skin immune cells, hormones, and neurotransmitters","volume":"42","author":"Pondeljak","year":"2020","journal-title":"Clin. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lugovi\u0107-Mihi\u0107, L., Me\u0161trovi\u0107-\u0160tefekov, J., Fer\u010dek, I., Pondeljak, N., Lazi\u0107-Mosler, E., and Ga\u0161i\u0107, A. (2021). Atopic dermatitis severity, patient perception of the disease, and personality characteristics: How are they related to quality of life?. Life, 11.","DOI":"10.3390\/life11121434"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/bjd.13497","article-title":"T-helper 2 immune skewing in pregnancy\/early life: Chemical exposures and development of atopic disease and allergy","volume":"172","author":"McFadden","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/exd.14014","article-title":"Interaction of peripheral nerves and mast cells, eosinophils, and basophils in the development of pruritus","volume":"28","author":"Nakashima","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuroscience.2020.07.048","article-title":"The posterior thalamic nucleus mediates histaminergic itch of the face","volume":"444","author":"Zhu","year":"2020","journal-title":"Neuroscience"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kong, S., Koo, J., and Lim, S.K. (2020). Association between stress and physical activity in Korean adolescents with atopic dermatitis based on the Korea Youth Risk Behavior Survey 2018\u20132019. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17218175"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1007\/s40279-018-0979-0","article-title":"The impact of regular physical activity and fitness on stress reactivity measured using the Trier Social Stress Test protocol: A systematic review","volume":"48","author":"Ludyga","year":"2018","journal-title":"Sports Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Siddiqui, A.F. (2023). Self-Perceived social support of patients with chronic skin diseases in Saudi Arabia: A cross-sectional survey. J. Clin. Med., 12.","DOI":"10.3390\/jcm12165406"},{"key":"ref_41","first-page":"174","article-title":"Quality of life of patients with atopic dermatitis","volume":"104","author":"Borza","year":"2019","journal-title":"Cutis"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Japund\u017ei\u0107, I., Bembi\u0107, M., \u0160piljak, B., Para\u0107, E., Macan, J., and Lugovi\u0107-Mihi\u0107, L. (2023). Work-Related Hand Eczema in Healthcare Workers: Etiopathogenic Factors, Clinical Features, and Skin Care. Cosmetics, 10.","DOI":"10.3390\/cosmetics10050134"},{"key":"ref_43","first-page":"293","article-title":"Occupational contact dermatitis amongst dentists and dental technicians","volume":"55","author":"Bulat","year":"2016","journal-title":"Acta Clin. Croat."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.anai.2019.07.008","article-title":"Real-world study evaluating the adequacy of existing systemic treatments for patients with moderate-to-severe atopic dermatitis (QUEST-AD): Baseline treatment patterns and unmet needs assessment","volume":"123","author":"Wei","year":"2019","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2017.08.002","article-title":"The burden of atopic dermatitis in adults in the United States: Data on healthcare resource utilization from the 2013 National Health and Wellness Survey","volume":"78","author":"Eckert","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2340\/00015555-3212","article-title":"Economic burden of adult patients with moderate-to-severe atopic dermatitis indicated for systemic treatment","volume":"99","author":"Shams","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/1346-8138.15366","article-title":"Cost-of-illness study for adult atopic dermatitis in Japan: A cross-sectional web-based survey","volume":"47","author":"Murota","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_48","first-page":"S57","article-title":"Economic burden and productivity loss associated with eczema: A prevalence-based follow-up study in Vietnam","volume":"69","author":"Le","year":"2019","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"S376","DOI":"10.1016\/j.jval.2019.04.1836","article-title":"PSY11 Work productivity and activity impairment among patients with atopic dermatitis in Taiwan","volume":"22","author":"Lin","year":"2019","journal-title":"Value Health"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"00294","DOI":"10.2340\/00015555-3653","article-title":"Impact of atopic dermatitis in adolescents and their parents: A French study","volume":"100","author":"Ezzedine","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/bjd.18296","article-title":"Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the UK, and the USA","volume":"182","author":"Andersen","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2340\/00015555-3117","article-title":"Health service utilization by 116,816 patients with atopic dermatitis in Israel","volume":"99","author":"Shalom","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaad.2017.04.019","article-title":"Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: Analysis using the National Health and Wellness Survey","volume":"77","author":"Eckert","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_54","first-page":"35","article-title":"Economic impact of atopic dermatitis in adults: A population-based study (IDEA study)","volume":"109","author":"Carrillo","year":"2018","journal-title":"Actas Dermosifiliogr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2340\/00015555-2741","article-title":"Suicidal ideation in adult patients with atopic dermatitis: A German cross-sectional study","volume":"97","author":"Gieler","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13555-020-00459-8","article-title":"Economic and psychosocial burden of comorbidities in adults with moderate to severe atopic dermatitis in Europe: A cross-sectional survey analysis","volume":"11","author":"Girolomoni","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaip.2017.10.024","article-title":"Healthcare resource utilization and costs among adults with atopic dermatitis in the United States: A claims-based analysis","volume":"6","author":"Drucker","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/jdv.15581","article-title":"The importance of out-of-pocket costs for adult patients with atopic dermatitis in France","volume":"33","author":"Launois","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/phpp.12479","article-title":"Narrowband ultraviolet B phototherapy improves quality of life in patients with psoriasis and atopic dermatitis up to 3 months: Results of an observational multicenter study","volume":"35","author":"Lauha","year":"2019","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"S745","DOI":"10.1016\/j.jval.2020.08.2024","article-title":"Health resource utilization and associated costs among patients with atopic dermatitis\u2014A retrospective cohort study based on German health claims data","volume":"23","author":"Schild","year":"2020","journal-title":"Value Health"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2500\/aap.2018.39.4175","article-title":"The burden of atopic dermatitis","volume":"39","author":"Reed","year":"2018","journal-title":"Allergy Asthma Proc."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jdv.14891","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part I","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.det.2024.05.001","article-title":"Topical therapy for atopic dermatitis: What is new and the new paradigm","volume":"42","author":"Buethe","year":"2024","journal-title":"Dermatol. Clin."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"558","DOI":"10.46747\/cfp.7009558","article-title":"Topical corticosteroids for atopic dermatitis","volume":"70","author":"Braschi","year":"2024","journal-title":"Can. Fam. Physician"},{"key":"ref_65","unstructured":"Silverberg, J.I., and Howe, W. (2024, September 18). Atopic Dermatitis (Eczema): Pathogenesis, Clinical Manifestations, and Diagnosis. Available online: https:\/\/www.uptodate.com\/contents\/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Shergill, M., Bajwa, B., Yilmaz, O., Tailor, K., Bouadi, N., and Mukovozov, I. (2024). Biologic and small molecule therapy in atopic dermatitis. Biomedicines, 12.","DOI":"10.3390\/biomedicines12081841"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1093\/bjd\/ljad442","article-title":"Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): A multicentre parallel group assessor-blinded clinical trial","volume":"190","author":"Flohr","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"ref_68","first-page":"23","article-title":"Immunosuppressive and immunomodulating therapy for atopic dermatitis in pregnancy: An appraisal of the literature","volume":"159","author":"Heilskov","year":"2024","journal-title":"Dermatol. Venerol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1080\/09546634.2022.2043545","article-title":"BIOREP Study Group. Dupilumab for the treatment of atopic dermatitis: Real-world data from the Czech Republic BIOREP registry","volume":"33","author":"Kojanova","year":"2022","journal-title":"J. Dermatol. Treat."},{"key":"ref_70","unstructured":"Berger, T.G. (2024, September 18). Evaluation and Management of Severe Refractory Atopic Dermatitis (eczema) in Adults. Available online: https:\/\/www.uptodate.com\/contents\/evaluation-and-management-of-severe-refractory-atopic-dermatitis-eczema-in-adults#H1361784051."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e39826","DOI":"10.1097\/MD.0000000000039826","article-title":"Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis in adolescents: A systematic review and meta-analysis of randomized controlled trials","volume":"103","author":"Huang","year":"2024","journal-title":"Medicine"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00105-022-05004-6","article-title":"Einsch\u00e4tzungen zur Therapie der moderaten bis schweren atopischen dermatitis mit januskinaseinhibitoren [Janus kinase inhibitors for the treatment of atopic dermatitis-evaluation of current data and practical experience]","volume":"73","author":"Lauffer","year":"2022","journal-title":"Dermatologie"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s00403-024-03325-1","article-title":"Analysis of patient experiences regarding JAK inhibitors for atopic dermatitis, psoriasis, alopecia areata, and vitiligo","volume":"316","author":"Sharma","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"ljae342","DOI":"10.1093\/bjd\/ljae342","article-title":"A Practical guide to using oral JAK Inhibitors for atopic dermatitis from the International Eczema Council","volume":"342","author":"Haag","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/jdv.20229","article-title":"Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis","volume":"38","author":"Silverberg","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.det.2024.06.003","article-title":"Atopic Dermatitis: The era of excellence in care","volume":"42","author":"Silverberg","year":"2024","journal-title":"Dermatol. Clin."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jaad.2017.06.042","article-title":"When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council","volume":"77","author":"Simpson","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2345739","DOI":"10.1080\/09546634.2024.2345739","article-title":"Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: A discrete choice experiment","volume":"35","author":"Feldman","year":"2024","journal-title":"J. Dermatol. Treat."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Chiei-Gallo, A., Barei, F., Calzari, P., Pisapia, A., Marzano, A.V., and Ferrucci, S.M. (Int. J. Dermatol., 2024). Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: A 3-year real-life study, Int. J. Dermatol., in press.","DOI":"10.1111\/ijd.17514"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.iac.2024.08.001","article-title":"Current and emerging biologics for atopic dermatitis","volume":"44","author":"Nevid","year":"2024","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2190430","DOI":"10.1080\/09546634.2023.2190430","article-title":"Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial","volume":"34","author":"Thyssen","year":"2023","journal-title":"J. Dermatol. Treat."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/02813432.2016.1160629","article-title":"Atopic dermatitis, asthma and allergic rhinitis in general practice and the open population: A systematic review","volume":"34","author":"Pols","year":"2016","journal-title":"Scan J. Prim. Health Care"},{"key":"ref_83","first-page":"210","article-title":"Oral allergy syndrome\u2014The need of a multidisciplinary approach","volume":"53","author":"Kelava","year":"2014","journal-title":"Acta Clin. Croat."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2215356","DOI":"10.1080\/09546634.2023.2215356","article-title":"Treatment preferences among patients with mild-to-moderate atopic dermatitis","volume":"34","author":"Myers","year":"2023","journal-title":"J. Dermatol. Treat."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1080\/09546634.2020.1832185","article-title":"Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment","volume":"33","author":"Boeri","year":"2022","journal-title":"J. Dermatol. Treat."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jdin.2024.03.019","article-title":"Improving systemic therapy selection for inflammatory skin diseases: A clinical need survey","volume":"16","author":"Brownstone","year":"2024","journal-title":"JAAD Int."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2308682","DOI":"10.1080\/09546634.2024.2308682","article-title":"Patients\u2019 preferences for systemic treatment of atopic dermatitis: Safety and efficacy count the most","volume":"35","author":"Schaarschmidt","year":"2024","journal-title":"J. Dermatol. Treat."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"058799","DOI":"10.1136\/bmjopen-2021-058799","article-title":"Patient preferences for atopic dermatitis medications in the UK, France and Spain: A discrete choice experiment","volume":"12","author":"Thomas","year":"2022","journal-title":"BMJ Open"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2222201","DOI":"10.1080\/09546634.2023.2222201","article-title":"Patient preferences for atopic dermatitis treatments: A discrete choice experiment","volume":"34","author":"Kwatra","year":"2023","journal-title":"J. Dermatol. Treat."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2304020","DOI":"10.1080\/09546634.2024.2304020","article-title":"Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: A discrete-choice experiment","volume":"35","author":"Feldman","year":"2024","journal-title":"J. Dermatol. Treat."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"adv24339","DOI":"10.2340\/actadv.v104.24339","article-title":"Patient preferences in the treatment of moderate-to-severe atopic dermatitis","volume":"104","author":"Ameen","year":"2024","journal-title":"Acta Derm. Venereol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/09546634.2019.1623860","article-title":"Patient and physician preferences for atopic dermatitis injection treatments in Japan","volume":"31","author":"Okubo","year":"2020","journal-title":"J. Dermatol. Treat."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/11\/1455\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:24:36Z","timestamp":1760113476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/11\/1455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":92,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ph17111455"],"URL":"https:\/\/doi.org\/10.3390\/ph17111455","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]}}}